Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMC STOP study
NL-OMON28468Recruiting
- Sponsor
- AMC Health
- Start
- Nov 2010
- Countries
- 1
01
Overview
Open-label trial in rheumatoid arthritis (RA), sponsored by AMC Health. Primary endpoints: Sustained drug-free remission at 24 months and Predictors of sustained drug-free remission. Started Nov 2010; status: recruiting.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON28468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28468.